Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.

NCT03947567 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Recombinant Human Coagulation FVIII

Sponsor

Sinocelltech Ltd.